Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference
- None.
- None.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in the panel discussion “The Next Generation of Proteomics from the Research and Clinical Perspectives” on Thursday, August 10, at 10:00 AM ET.
Additionally, Jeff Hawkins will participate in a fireside chat on Thursday, August 10, at 12:30 PM ET.
A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing CompanyTM, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230726447394/en/
Investor
Juan Avendano
ir@quantum-si.com
Media
Michael Sullivan
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
What event is Quantum-Si participating in?
When will Jeff Hawkins be speaking at the conference?
Where can the webcast of the event be accessed?
